More research is needed to address barriers to therapeutic monitoring of prostate cancer patients on androgen deprivation therapy, according to researchers.
Progress on this transformative, state-of-the-art project, which is part of a £50 million capital investment funded by Harrogate and District NHS Foundation Trust (HDFT) and NHS England, took a ...